Q:

Which of the following genetic abnormalities defines a favorable prognosis group?

0

A LJ8-year-old male presen ts to the emergency room for further evaluation of a 3-week history of progressively worsening Fatigue. Physical examination reveals pal lor and dif-Fuse petech iae over lower extremities. Laboratory evaluation shows a total leukocyte cou nt of 2 3, LJOO/,uL. hemoglobin 9.8 g/dl. and platelet count of 1 3, 000/,uL. Periph-eral blood smear and bone marrow aspirate are shown.

Which of the following genetic abnormalities defines a favorable prognosis group?


  1. FLT3-ITD+, NPMl+
  2. Monoallelic CEBPA+, FLT3-ITD-
  3. NPM1+, FLT3-ITD-
  4. Biallelic CEBPA+, FLT3-ITD+
  5. NPMl-, FLT3-ITD-

All Answers

need an explanation for this answer? contact us directly to get an explanation for this answer

C. Presence of NPM1 mutation confers favorable prognosis in AML patients with normal cytogenetics, while FLT3-ITD is associated with poor outcomes. The presence ofbiallelic mutations in CEBPA is associated with a favorable mutation. Monoallelic CEBPA mutations do not appear to pre-dict the same favorable outcome (Blood. 201 1;1 18(4): 1 069, Blood. 20 1 1;118(20):5593, Blood.20 10;11 5(3 ):453).

need an explanation for this answer? contact us directly to get an explanation for this answer

total answers (1)

Similar questions


need a help?


find thousands of online teachers now